Nathan Wood is the CEO and Board Member of KromaTiD. Nathan has nearly 30 years of proven experience in the life sciences industry. He has held leadership roles in sales, marketing, product development and management at several companies in the genomics and life sciences industries, including Life Technologies Corporation and QIAGEN Inc. Nathan served on BIOCOM’s Renewables Advisory Board. He has also served on the Board of Directors of GeneArt, Blue Heron, SB Biofuels and the College of Science at Oregon State University.
Most recently, Nathan served as CEO at Swift Biosciences. Under his leadership, Swift grew quickly by effectively leveraging new products and marketing strategies. Additionally, Nathan’s experience—across European and American multinational companies—spans strategic planning, financial performance measurement and global business strategy.